| A genetically modified minipig model for Alzheimer’s disease with SORL1 haploinsufficiency OM Andersen, N Bøgh, AM Landau, GG Pløen, AMG Jensen, G Monti, ... Cell Reports Medicine 3 (9), 2022 | 34 | 2022 |
| GLP-1 receptor agonists in neurodegeneration: neurovascular unit in the spotlight G Monti, D Gomes Moreira, M Richner, HAM Mutsaers, N Ferreira, A Jan Cells 11 (13), 2023, 2022 | 23 | 2022 |
| Finding memo: versatile interactions of the VPS10p-Domain receptors in Alzheimer’s disease A Salasova, G Monti, OM Andersen, A Nykjaer Molecular Neurodegeneration 17 (1), 74, 2022 | 18 | 2022 |
| An alternative transcript of the Alzheimer's disease risk gene SORL1 encodes a truncated receptor J Blechingberg, ASA Poulsen, M Kjølby, G Monti, M Allen, AK Ivarsen, ... Neurobiology of aging 71, 266. e11-266. e24, 2018 | 13 | 2018 |
| Expression of an alternatively spliced variant of SORL1 in neuronal dendrites is decreased in patients with Alzheimer’s disease G Monti, M Kjolby, AMG Jensen, M Allen, J Reiche, PL Møller, ... Acta neuropathologica communications 9, 1-18, 2021 | 12 | 2021 |
| Relying on the relationship with known disease-causing variants in homologous proteins to predict pathogenicity of SORL1 variants in Alzheimer’s disease OM Andersen, G Monti, AMG Jensen, M de Waal, M Hulsman, JG Olsen, ... BioRxiv, 2023.02. 27.524103, 2023 | 6 | 2023 |
| The SORL1 p.Y1816C variant causes impaired endosomal dimerization and autosomal dominant Alzheimer’s disease AMG Jensen, J Raska, P Fojtik, G Monti, M Lunding, S Bartova, ... Proceedings of the National Academy of Sciences 121 (37), e2408262121, 2024 | 5 | 2024 |
| 20 Years Anniversary for SORLA/SORL1 G Monti, OM Andersen Receptors & Clinical Investigation 6, 2019 | 5 | 2019 |
| In vivo evidence that SORL1, encoding the endosomal recycling receptor SORLA, can function as a causal gene in Alzheimer’s Disease OM Andersen, N Bøgh, AM Landau, GG Pløen, AMG Jensen, G Monti, ... bioRxiv, 2021.07. 13.452149, 2021 | 3 | 2021 |
| Epitope mapping of nanobodies binding the Alzheimer’s disease receptor SORLA G Monti, C Vincke, M Lunding, AMG Jensen, P Madsen, S Muyldermans, ... Journal of Biotechnology 375, 17-27, 2023 | 1 | 2023 |
| Identification of regulators of microglia lipotoxicity M Therrien, N Weider, G Monti, D Meyer, T Atkeson, S McCarroll, A Greka, ... Alzheimer's Association International Conference, 2024 | | 2024 |
| Finding Memo: Versatile interactions of the VPS10p receptors in Alzheimer’s disease A Salasova, G Monti, OM Andersen, A Nykjaer | | 2022 |
| Finding memo: versatile interactions of the VPS10p-Domain receptors in Alzheimer’s A Salasova, G Monti, OM Andersen, A Nykjaer | | 2022 |
| SORLA Expression in Synaptic Plexiform Layers of Mouse Retina G Monti, ML Jensen, A Mehmedbasic, MM Jørgensen, IE Holm, P Barkholt, ... Molecular Neurobiology 57, 3106-3117, 2020 | | 2020 |
| EXPRESSION OF THE ALZHEIMER’S DISEASE RISK FACTOR SORLA IN THE POSTNATAL MOUSE RETINA M Melnikova Alzheimer's & Dementia, 2019 | | 2019 |
| P4‐259: A NOVEL SORL1 TRANSCRIPT THAT IS DOWNREGULATED IN ALZHEIMER'S DISEASE G Monti, MF Kjølby, RC Barò, N Wellner, J Reiche, SJ Lincoln, M Allen, ... Alzheimer's & Dementia 14 (7S_Part_29), P1545-P1546, 2018 | | 2018 |
